Moderna’s cancer vaccine hits its targets, but an embargo breach rattles investors and the stock tumbles
Published . Updated .
Questions of a ‘sell-the-news reaction.’ The experimental treatment helped prevent the return of cancer or death in melanoma patients by 42% after two years
Directly affected
- MRNA Moderna+67.6%
Named in this report.
Indirectly affected
- XLE Energy Select Sector SPDR+4.9%
Energy prices move when sanctioned supply is blocked
- USO United States Oil Fund+0.9%
This fund moves with oil prices
- XOM Exxon Mobil+7.9%
Oil producers move when sanctioned barrels leave the market
- CVX Chevron+6.6%
Oil producers move when sanctioned barrels leave the market
- SLB SLB-4.1%
Oilfield work in sanctioned regions can be cut off
- GLD SPDR Gold Shares-3.3%
Gold is a usual haven when a conflict or sanction escalates
- LMT Lockheed Martin+4.2%
Defense contractors get more work when conflict spending rises
- SPY SPDR S&P 500+1.6%
The broad market moves when a major sanction lands
Price reaction, T-5 to T+3
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Questions of a ‘sell-the-news reaction.’ The experimental treatment helped prevent the return of cancer or death in melanoma patients by 42% after two years
Source: MarketWatch
Trades by members of Congress and officials in the stocks in this story
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 28 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 48 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Moderna (MRNA), worth $1,001 - $15,000 on 28 Aug 2026. That is 55 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Kevin Hern sold ExxonMobil Holdings (XOM) (jointly held), worth $100,001 - $250,000 on 31 Aug 2026. That is 52 days before publication. Filed 25 Sep 2026. View the filing.
- Donald J Trump, an executive branch official, bought ExxonMobil Holdings (XOM), worth $250,001 - $500,000 on 31 Jul 2026. That is 83 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Kevin Hern sold Chevron (CVX) (jointly held), worth $15,001 - $50,000 on 23 Sep 2026. That is 29 days before publication. Filed 13 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Chevron (CVX), worth $1,001 - $15,000 on 2 Sep 2026. That is 50 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, sold Chevron (CVX), worth $15,001 - $50,000 on 31 Jul 2026. That is 83 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Kevin Hern sold Lockheed Martin (LMT) (jointly held), worth $15,001 - $50,000 on 23 Sep 2026. That is 29 days before publication. Filed 13 Oct 2026. View the filing.
- Rep. Kevin Hern sold Lockheed Martin (LMT) (jointly held), worth $15,001 - $50,000 on 23 Sep 2026. That is 29 days before publication. Filed 13 Oct 2026. View the filing.
- Rep. Kevin Hern sold Lockheed Martin (LMT) (jointly held), worth $15,001 - $50,000 on 17 Sep 2026. That is 35 days before publication. Filed 13 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“Moderna’s cancer vaccine hits its targets, but an embargo breach rattles investors and the stock tumbles” scores 12 out of 100. The score uses 1 sources.